Clinical Trials Browser

Phase EARLY_PHASE1 × Plasmablastic Lymphoma × 1 year × Clear all

NCT04139304 2025-06-29

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

Phase EARLY_PHASE1 Recruiting

Plasmablastic Lymphoma